Progress of studies on enhancing efficiency of gene transfection into hematopoietic cells with the adenoviral vector--review / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 383-386, 2004.
Article
em Zh
| WPRIM
| ID: wpr-352058
Biblioteca responsável:
WPRO
ABSTRACT
Recombinant adenoviral vectors have been widely applied for the basic research and clinical trials of gene therapy. However, the inability of adenovirus to infect hematopoietic cells which lack the specific adenovirus receptors-coxsackie virus and adenovirus receptor (CAR) represents an important limitation in therapeutic applications. This limitation may be overcome by several approaches including modification of adenovirus vector and improvement of the susceptibility of hematopoietic cells. The current progresses in this field were summarized.
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Receptores Virais
/
Células-Tronco Hematopoéticas
/
Transfecção
/
Terapia Genética
/
Adenoviridae
/
Proteína de Membrana Semelhante a Receptor de Coxsackie e Adenovirus
/
Genética
/
Metabolismo
Limite:
Humans
Idioma:
Zh
Revista:
Journal of Experimental Hematology
Ano de publicação:
2004
Tipo de documento:
Article